Kenvue Names WPP and Publicis Groupe as Global Agency Partners After Worldwide Review

Kenvue has concluded a comprehensive global agency review, appointing WPP and Publicis Groupe as its new worldwide agency partners, according to a global industry report. The decision marks a significant shift in the consumer health major’s global marketing and communications strategy as it looks to streamline creativity, media and commerce across markets.

Under the new arrangement, WPP will lead creative strategy and production across Kenvue’s brand portfolio globally, covering all channels and markets except Neutrogena. Publicis Groupe will handle media, commerce, healthcare communications and technology services for all Kenvue brands worldwide, while also taking charge of creative and production responsibilities for Neutrogena. Publicis already manages Kenvue’s media business in the Asia-Pacific region, giving it a broader global role under the renewed partnership.

The review spanned Kenvue’s extensive brand portfolio, which includes major names such as Tylenol, Listerine and Neutrogena. As per COMvergence estimates cited in the report, Kenvue’s global media spend stood at approximately $1.35 billion in 2025, highlighting the scale of the mandate awarded to the two holding groups.

The timing of the agency appointments is particularly notable for Tylenol, which experienced a challenging year after the Trump administration raised concerns in 2025 regarding the use of acetaminophen during pregnancy. These claims were strongly disputed by the medical community, and Kenvue maintained a cautious, evidence-based communications approach as related legal proceedings unfolded.

The agency reshuffle also comes amid broader leadership changes at Kenvue. In October 2025, the company appointed Jon Halvorson to a newly created role that combines global marketing leadership with digital commerce strategy, signalling a sharper focus on integrated brand building and performance-led growth.